A pilot phase I dose finding safety study of the thrombopoietin-receptor agonist, eltrombopag, in patients with myelodysplastic syndrome treated with azacitidine.
- Submitting institution
-
University of Oxford
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 16036
- Type
- D - Journal article
- DOI
-
10.1111/ejh.12383
- Title of journal
- European journal of haematology
- Article number
- -
- First page
- 439
- Volume
- 93
- Issue
- 5
- ISSN
- 0902-4441
- Open access status
- Out of scope for open access requirements
- Month of publication
- June
- Year of publication
- 2014
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
7
- Research group(s)
-
-
- Citation count
- 24
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -
